Monoclonal Antibodies The approach (s), which is/are currently followed to produce human monoclonal antibodies, is/are known as hybridization of 6-thioguanine-resistant human plasmacytoma with immune human lymphocytes combination of EB Vand hybridoma techniques all of these transformation of antigen specific B lymphocytes (EBV) hybridization of 6-thioguanine-resistant human plasmacytoma with immune human lymphocytes combination of EB Vand hybridoma techniques all of these transformation of antigen specific B lymphocytes (EBV) ANSWER DOWNLOAD EXAMIANS APP
Monoclonal Antibodies Some cross reactions with monoclonal antibodies (MAbs) can occur. Unexpected cross reactions occur more frequently with IgE IgG IgA Ig MAbs IgE IgG IgA Ig MAbs ANSWER DOWNLOAD EXAMIANS APP
Monoclonal Antibodies Preliminary clinical results with a humanized antibody against the interleukin-2 receptor have suggested the absence of human immune response against murine proteins (HAMA) response All of these poor recognition of immunoglobulin, Ig constant regions presence of HAMA response absence of human immune response against murine proteins (HAMA) response All of these poor recognition of immunoglobulin, Ig constant regions presence of HAMA response ANSWER DOWNLOAD EXAMIANS APP
Monoclonal Antibodies The cross linkage of antigens by antibodies is known as all of these agglutination a cross reaction complement fixation all of these agglutination a cross reaction complement fixation ANSWER DOWNLOAD EXAMIANS APP
Monoclonal Antibodies In monoclonal antibody technology, tumor cells that can replicate endlessly are fused with mammalian cells that produce an antibody. The result of this cell fusion is a natural killer cell hybridoma lymphoblast myeloma natural killer cell hybridoma lymphoblast myeloma ANSWER DOWNLOAD EXAMIANS APP
EXAMIANS